International Biotechnology Trust PLC Travere Therapeutics, Inc. Transaction History

International Biotechnology Trust PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$15.3 - $22.61 $4.59 Million - $6.78 Million	300,000 Added 212.74%	441,019 $6.77 Million
Q1 2023 May 18, 2023	SELL	$17.82 - $22.89 $4.24 Million - $5.45 Million	-238,000 Reduced 62.79%	141,019 $3.17 Million
Q4 2022 Feb 01, 2023	BUY	$18.47 - $26.14 $3.56 Million - $5.05 Million	193,000 Added 103.75%	379,019 $7.97 Million
Q3 2022 Nov 08, 2022	BUY	$22.91 - $28.63 $4.05 Million - $5.06 Million	176,804 Added 1918.65%	186,019 $4.58 Million
Q2 2022 Aug 16, 2022	SELL	$20.94 - $30.01 $7.76 Million - $11.1 Million	-370,785 Reduced 97.58%	9,215 $380 Million
Q3 2021 Nov 12, 2021	BUY	$12.98 - $25.03 $4.67 Million - $9.01 Million	360,000 Added 1800.0%	380,000 $9.22 Million
Q4 2020 Feb 19, 2021	BUY	$19.17 - $27.87 $383,400 - $557,400	20,000 New	20,000 $545,000

196

84.9M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.